Procaps Group (PROC) Competitor Comparison
We are evaluating the key criteria listed to compare Procaps Group (PROC) against its competitors in the Drug Manufacturers - Specialty & Generic industry.
Market Capitalization
31 / 54Gross Profits
0 / 39Total Revenue
27 / 50EBITDA
22 / 53Free Cashflow
39 / 54Quick Ratio
39 / 54Earnings per Share
11 / 54Dividend yield
0 / 5Total Cash
44 / 54Performance 3 years
42 / 54Performance 5 years
40 / 54Performance 10 years
39 / 54Linearity 3 years
34 / 54Linearity 5 years
31 / 54Linearity 10 years
28 / 54Total Rank
14 / 54Dividend Rank
31 / 54Valuation Rank
17 / 54Piotroski Rank
15 / 54Muliplier Rank
16 / 54Performance 10 years - PROC ranking 39 / 54
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.